Direct-to-consumer genetic testing involves the marketing of genetic tests directly to consumers through media such as radio, television, print adverts, and the internet, where customers can purchase the tests through online marketplaces and pharmacies. After purchasing a test kit, clients give the business a DNA sample and provide individuals access to their genetic data without necessarily requiring the involvement of a healthcare professional or health insurance provider via a secure website, app, or written report with their results.
The main types of direct-to-consumer (DTC) genetic testing include carrier testing, predictive testing, ancestry and relationship testing, nutrigenomic testing and other types. Carrier screening is a type of genetic test that assesses whether or not a person carries an alteration in one of their genes for a certain genetic disorder. They are used to test saliva, urine and blood samples by using different technologies such as single nucleotide polymorphism chips whole genome sequencing and targeted analysis. They are conducted in different business models such as health planning model, comprehensive genome tests model, medical precision tests model and restricted trait tests model and for use by various end-users including laboratories, blood banks, nursing homes, hospitals, imaging centers, home care, cosmetics and others.
The direct-to-consumer (DTC) genetic testing market research report is one of a series of new reports from The Business Research Company that provides direct-to-consumer (DTC) genetic testing market statistics, including direct-to-consumer (DTC) genetic testing industry global market size, regional shares, competitors with a direct-to-consumer (DTC) genetic testing market share, detailed direct-to-consumer (DTC) genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the direct-to-consumer (DTC) genetic testing industry. This direct-to-consumer (DTC) genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The global direct-to-consumer (DTC) genetic testing market size is expected to grow from $1.35 billion in 2022 to $1.58 billion in 2023 at a compound annual growth rate (CAGR) of 16.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global direct-to-consumer (DTC) genetic testing market size is expected to grow to $2.81 billion in 2027 at a CAGR of 15.5%.
The rising prevalence of diseases and disorders with genetic transmission capabilities is expected to propel the growth of the direct-to-consumer (DTC) genetic testing market going forward. Genetic disorder refers to an illness caused by changes (mutation) in a person's DNA and it includes single-gene, multifactorial and chromosomal disorders. Direct-to-consumer genetic testing promotes awareness of various genetic disorders that helps in making predictions about health and provides personalized information about an individual’s health, disease risk, and other traits, thus, helps in taking effective health and lifestyle decisions to reduce the disease risk. For instance, according to MedlinePlus, a US-based online information service provided by the United States National Library of Medicine, in 2021, syndrome A is identified in about 1 in 200,000 Americans each year and currently around 100,000 kids suffer from syndrome B, whereas, it is estimated that nearly 12,000 people died globally from syndrome C in 2020 and approximately 1% of people in the United States develop disorder D during their lifetimes. Furthermore, in February 2022, according to the World Health Organization (WHO), a Switzerland-based agency of the United Nations responsible for international public health, birth abnormalities cause 240,000 new-borns to pass away in the first 28 days of life each year and an additional 170,000 children between the ages of 1 month and 5 years die as a result of birth abnormalities which includes heart defects, neural tube defects, and Down syndrome (a genetic disorder). Therefore, the rising prevalence of diseases and disorders with genetic transmission capabilities is driving the growth of the direct-to-consumer (DTC) genetic testing market.
Technological advancement is a key trend gaining popularity in the direct-to-consumer (DTC) genetic testing market. Major companies operating in the direct-to-consumer (DTC) genetic testing market are focused on developing technologically advanced solutions to sustain their position in the market. For instance, in March 2020, Superdrug Stores Plc, a UK-based health and beauty retailer, launched CircleDNA, an advanced home DNA test kit that uses next-generation sequencing (NGS) technology. The new technology is capable of offering whole-exome sequencing which measures 31 million DNA positions per person and can detect more than 90% of cancer mutations. Additionally, it provides test findings including cancer risk, illnesses, and brain health to discover actionable insights into their genetic blueprint which can be crucial for people and help them modify their lifestyles for the better.
In March 2022, LetsGetChecked, a US-based virtual care company that offers at-home testing, telehealth services, and pharmacy capabilities acquired Veritas Genetics for an undisclosed amount. Through this acquisition, LetsGetChecked aims to utilize whole-genome sequencing to start a full lifecycle of personalized healthcare to provide the market's most complete range of health testing and care options. Veritas Genetics is a US-based biotechnology company for personal genomics.
Major players in the direct-to-consumer (dtc) genetic testing market are 23andMe Holding Co., Ancestry.com LLC, Color Health Inc., EasyDNA, Full Genomes Corporation, Helix, Identigene LLC, Living DNA, MyHeritage Ltd., FamilyTreeDNA, Myriad Genetics Inc., Quest Diagnostics, Mapmygenome, Genesis HealthCare, Gene by Gene, Laboratory Corporation of America Holdings, Positive Bioscience, Sonora Quest Laboratories, Xcode Life Sciences Private Limited, 24Genetics, Konica Minolta Inc., Direct Laboratory Services LLC, Prenetics Global, Karmagenes, Pathway Genomics, Request A Test Ltd., Any Lab Test Now, Dante Labs, Fulgent Genetics, and Victorian Clinical Genetics Services.
North America was the largest region in the direct-to-consumer (DTC) genetic testing market in 2022. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the global direct-to-consumer (DTC) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the direct-to-consumer (DTC) genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The direct-to-consumer (DTC) genetic testing market includes revenues earned by entities by offering DTC genetic kits and services straight to end-customers, that are used in querying patients' DNA information. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The global direct-to-consumer (DTC) genetic testing market is segmented -
1) By Type: Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types
2) By Sample: Saliva, Urine, Blood
3) By Technology: Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis
4) By Business Model: Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode
5) By End User: Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centres, Home Care, Cosmetics, Other End-User